CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma

gan Quintás-Cardama, Alfonso
Cyhoeddwyd yn Oncotarget (2018)

Molecular biology of bcr-abl1–positive chronic myeloid leukemia

gan Quintás-Cardama, Alfonso, Cortes, Jorge
Cyhoeddwyd 2009

Bullet ‘Manicure’: Does Lead Prevent Hydroxyurea-induced Cutaneous Toxicity?

gan Falchi, Lorenzo, Quintás-Cardama, Alfonso
Cyhoeddwyd yn Jpn J Clin Oncol (2014)

MOLECULAR PATHWAYS: JAK/STAT PATHWAY: MUTATIONS, INHIBITORS, AND RESISTANCE

gan Quintás-Cardama, Alfonso, Verstovsek, Srdan
Cyhoeddwyd yn Clin Cancer Res (2013)

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans

gan Pant, Vinod, Quintás-Cardama, Alfonso, Lozano, Guillermina
Cyhoeddwyd 2012

ADVANCES AND CONTROVERSIES IN THE DIAGNOSIS, PATHOGENESIS, AND TREATMENT OF SYSTEMIC MASTOCYTOSIS

gan Quintás-Cardama, Alfonso, Jain, Nitin, Verstovsek, Srdan
Cyhoeddwyd yn Cancer (2011)

The Changing Mutational Landscape of Acute Myeloid Leukemia and Myelodysplastic Syndrome

gan Larsson, Connie A., Cote, Gilbert, Quintás-Cardama, Alfonso
Cyhoeddwyd 2013

Investigational Immunotherapeutics for B-Cell Malignancies

gan Quintás-Cardama, Alfonso, Wierda, William, O'Brien, Susan
Cyhoeddwyd yn J Clin Oncol (2010)

Monitoring Molecular Response in Chronic Myeloid Leukemia

gan Cortes, Jorge, Quintás-Cardama, Alfonso, Kantarjian, Hagop M.
Cyhoeddwyd yn Cancer (2010)

Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia

gan Quintás-Cardama, Alfonso, Han, Xin, Kantarjian, Hagop, Cortes, Jorge
Cyhoeddwyd 2009

Early Cytogenetic and Molecular Response During First-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase: Long-Term Implications

gan Quintás-Cardama, Alfonso, Cortes, Jorgé E., Kantarjian, Hagop M.
Cyhoeddwyd 2011

p53 pathway dysfunction in AML: beyond TP53 mutations

gan Post, Sean M., Kornblau, Steven M., Quintás-Cardama, Alfonso
Cyhoeddwyd yn Oncotarget (2017)

Prognostic Impact of the MDM2(SNP309) Allele in Leukemia and Lymphoma

gan Post, Sean M., Pant, Vinod, Abbas, Hussein, Quintás-Cardama, Alfonso
Cyhoeddwyd 2010

Evolution of Therapies for Chronic Myelogenous Leukemia

gan Santos, Fabio P S, Kantarjian, Hagop, Quintás-Cardama, Alfonso, Cortes, Jorge
Cyhoeddwyd 2011

THE RISE AND FALL OF GAKEKEEPER MUTATIONS? THE BCR-ABL1(T315I) PARADIGM

gan Gibbons, Don L., Pricl, Sabrina, Cortes, Jorge, Quintás-Cardama, Alfonso
Cyhoeddwyd yn Cancer (2011)

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability

gan Pant, Vinod, Xiong, Shunbin, Iwakuma, Tomoo, Quintás-Cardama, Alfonso, Lozano, Guillermina
Cyhoeddwyd 2011

Prognostic Model to Identify Patients With Myelofibrosis at the Highest Risk of Transformation to Acute Myeloid Leukemia

gan Quintás-Cardama, Alfonso, Kantarjian, Hagop, Pierce, Sherry, Cortes, Jorge, Verstovsek, Srdan
Cyhoeddwyd 2013

Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis

gan Quintás-Cardama, Alfonso, Sever, Matjaz, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Cyhoeddwyd yn Leuk Lymphoma (2013)

SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH POLYCYTHEMIA VERA

gan Sever, Matjaz, Quintás-Cardama, Alfonso, Pierce, Sherry, Zhou, Lingsha, Kantarjian, Hagop, Verstovsek, Srdan
Cyhoeddwyd 2013

PREDICTING OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT ANY TIME DURING TYROSINE KINASE INHIBITOR THERAPY

gan Quintás-Cardama, Alfonso, Choi, Sangbum, Kantarjian, Hagop, Jabbour, Elias, Huang, Xuelin, Cortes, Jorge
Cyhoeddwyd 2014